Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Advanced Oncotherapy
Life Sciences
LIGHT: regulatory update
By
Dr Martin Hall
14 Mar 2022
Pantheon International Plc
Investment Companies
1H strong performance, actively managed portfolio
By
Mark Thomas
04 Mar 2022
Shield Therapeutics Plc
Life Sciences
PBMs have bought in to Accrufer
By
Dr Martin Hall
02 Mar 2022
The Monthly: March 2022
02 Mar 2022
ICG Enterprise Trust
Investment Companies
Spotlight on secondaries
By
Mark Thomas
02 Mar 2022
City of London Investment Group
Investment Companies
Confirming an excellent first half
By
Dr Brian Moretta
23 Feb 2022
Volta Finance
Investment Companies
What Volta brings to investors
By
Mark Thomas
17 Feb 2022
Real Estate Credit Investments (RECI)
Investment Companies
Vive la difference
By
Mark Thomas
15 Feb 2022
Cornerstone
Technology
Acquisition of Capital Currencies Ltd
By
Milan Radia
14 Feb 2022
Oakley Capital Investments
Investment Companies
Educating on education
By
Mark Thomas
09 Feb 2022
Cizzle Biotechnology
Life Sciences
Strategic alliance in China
By
Dr Martin Hall
08 Feb 2022
Prev
1
...
20
21
22
23
24
...
81
Next